{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:37:37Z","timestamp":1792705057875,"version":"4.5.0"},"reference-count":35,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"National Health and Medical Research Council","award":["2024589"],"award-info":[{"award-number":["2024589"]}]},{"name":"Australian Government Department of Health, Disability and Aging","award":["GO6587"],"award-info":[{"award-number":["GO6587"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Breastfeeding Medicine"],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Potential milk donors should be carefully screened to ensure that donated human milk is safe for vulnerable infant recipients. Some medications and supplements may result in donor deferral or make donation impossible. However, evidence about medication or supplement exposures among those considering donating excess breast milk in Australia remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To examine medication and supplement use among pre-eligibility donors to an Australian nonprofit milk bank.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective cross-sectional study analyzed 1,480 high-level screening questionnaires completed at the Australian Red Cross Lifeblood milk bank between January 2023 and December 2024. All medications and supplements reportedly taken during the 10 weeks preceding the pre-eligibility donor screening interview were extracted, categorized, and summarized descriptively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Screening occurred a median of 9.7 weeks postpartum. Overall, 90% of pre-eligibility donors reported using either medications (75.2%) or supplements (64.1%), with many using both. Analgesics were most common (taken by 61.9%), followed by anticoagulants (22.1%), antibiotics (14.7%), hormonal therapies (11%), and antihypertensives (7%). Overall, 46.5% reported using at least one short-term medication associated with temporary deferral, and 12.4% were taking a long-term medication at screening that could have led to ineligibility. Multivitamins were the most commonly taken supplement (44.5% of all pre-eligibility donors).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Medications were primarily short-term treatments for postpartum care. Supplement use was prevalent, with multiple products taken. Given the limited safety data for many medications and supplements in the context of donor milk, these findings highlight the need for clearer, evidence-based guidance to support safe and inclusive donor eligibility decisions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/15568253261480492","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:00:47Z","timestamp":1792501247000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of Medication and Supplement Use Among Pre-Eligibility Milk Bank Donors: An Australian Retrospective Cross-Sectional Study"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7614-931X","authenticated-orcid":false,"given":"Claire","family":"Newman","sequence":"first","affiliation":[{"name":"Australian Red Cross Lifeblood, West Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura D.","family":"Klein","sequence":"additional","affiliation":[{"name":"Australian Red Cross Lifeblood, West Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitch","family":"Booth","sequence":"additional","affiliation":[{"name":"Australian Red Cross Lifeblood, West Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Grzeskowiak","sequence":"additional","affiliation":[{"name":"College of Medicine and Public Health, Flinders University, Bedford Park, Australia."},{"name":"SA Pharmacy, Flinders Medical Centre, SA Health, Bedford Park, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Clifford","sequence":"additional","affiliation":[{"name":"Australian Red Cross Lifeblood, West Melbourne, Australia."},{"name":"Royal Children\u2019s Hospital, Parkville, Australia."},{"name":"Murdoch Children\u2019s Research Institute, Parkville, Australia."},{"name":"University of Melbourne, Parkville, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.2008.26811B"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anpede.2015.07.035"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/mcn.13657"},{"issue":"6","key":"e_1_3_5_5_1","first-page":"638","article-title":"Medication safety in breastfeeding","volume":"106","author":"Spencer JP","year":"2022","unstructured":"4.Spencer JP, , Thomas S, , Pawlowski RHT. Medication safety in breastfeeding. Am Fam Physician 2022;106(6):638\u2013644. Available from: https:\/\/www.aafp.org\/pubs\/afp\/issues\/2022\/1200\/medication-safety-breastfeeding.html","journal-title":"Am Fam Physician"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/0890334419888156"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1089\/bfm.2022.0207"},{"key":"e_1_3_5_8_1","unstructured":"7.HMBANA. Guidelines for the establishment and operation of a donor human milk bank 2024. Available from: https:\/\/www.hmbana.org\/file_download\/inline\/78058d21-b0c4-48e7-93ca-6f64445a91f7 [Last accessed: June11 2024]."},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00053"},{"key":"e_1_3_5_10_1","unstructured":"9.H\u00e9ma-Qu\u00e9bec. Accepted medications. Canada: H\u00e9ma-Qu\u00e9bec 2026. Available from: https:\/\/www.hemaquebec.ca\/en\/mothers-milk-donation\/who-can-give-mothers-milk\/medication"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/mcn.13564"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/jpc.14909"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.aucc.2024.03.004"},{"key":"e_1_3_5_14_1","unstructured":"13.FDA. General Drug Categories. U.S. Department of Health and Human Services 2015. Available from: https:\/\/www.fda.gov\/drugs\/investigational-new-drug-ind-application\/general-drug-categories"},{"key":"e_1_3_5_15_1","unstructured":"14.FDA. Dietary Supplements. U.S. Department of Health and Human Services 2024. Available from: https:\/\/www.fda.gov\/food\/dietary-supplements"},{"key":"e_1_3_5_16_1","unstructured":"15.Rossello J. Types of Dietary Supplements. 2024. Available from: https:\/\/www.preventivemedicinedaily.com\/general\/types-of-dietary-supplements\/#7-enzymes"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-025-02443-6"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018024802"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2732"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajo.13587"},{"key":"e_1_3_5_21_1","unstructured":"20.Jones W. Rivaroxaban and other anticoagulants and breastfeeding 2024. Available from: https:\/\/breastfeeding-and-medication.co.uk\/fact-sheet\/rivaroxaban-and-other-anticoagulants-and-breastfeeding [Last accessed: March27 2026]."},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ogc.2023.02.009"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30773-1"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2025-084312"},{"key":"e_1_3_5_25_1","unstructured":"24.Australian Bureau of Statistics. Dietary supplements. ABS 2023. Available from: https:\/\/www.abs.gov.au\/statistics\/health\/food-and-nutrition\/dietary-supplements\/latest-release"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1097\/aog.0000000000003657"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13006-024-00687-0"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1089\/bfm.2023.0172"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2016.02.013"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114523002775"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2020.1753650"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13006-020-00354-0"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/1541-4337.70288"},{"key":"e_1_3_5_34_1","unstructured":"33.Coupland K Klein LD Grzeskowiak L et al. A narrative review of nutritional supplement concentrations in human milk in order to establish safe upper intake levels for milk donors [Conference abstract]. International Donor Milk Conference. Austin Texas USA; 2024."},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu15132823"},{"key":"e_1_3_5_36_1","unstructured":"35.Therapeutic Goods Administration (TGA). Stronger safety controls to be introduced for products containing vitamin B6 [media release]. Canberra: Australian Governement Department of Heatlh and Aged Care 2025. Available from: https:\/\/www.tga.gov.au\/news\/media-releases\/stronger-safety-controls-be-introduced-products-containing-vitamin-b6"}],"container-title":["Breastfeeding Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15568253261480492","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/15568253261480492","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/15568253261480492","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:46:25Z","timestamp":1792701985000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/15568253261480492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":35,"alternative-id":["10.1177\/15568253261480492"],"URL":"https:\/\/doi.org\/10.1177\/15568253261480492","relation":{},"ISSN":["1556-8253","1556-8342"],"issn-type":[{"value":"1556-8253","type":"print"},{"value":"1556-8342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"article-number":"15568253261480492"}}